BDXBecton Dickinson
$183.72+26% 1Y
$183.72
$136.0952 weeks$192.00
BDX in its own filings
Nothing in BDX's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
620
Events found in the filings · across 3,000 filings · the record starts in 1998
- Hard flags
- none
Hard flags
- Most recent filing
- Aug 6, 2026
Most recent filing · Form 8-K
- Record starts
- Dec 16, 1998
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 5, 2026
- Security removed from listing or deregistered12 occurrences · usually a matured note or preferred class, not the common shares
- 2026-06-04
- SEC comment-letter activity48 occurrences
- 2023-06-06
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 6, 2026BD Reports Third Quarter Fiscal 2026 Financial Results.Earnings release · press release
- Jul 22, 2026On July 19, 2026, Michael D. Garrison, Executive Vice President and President of the Medical Essentials and BioPharma Systems segments of Becton, Dickinson and Company (“BD”), informed BD of his intention to retire.Director or officer change · Form 8-K
- May 20, 2026Subsidiary Notes Offering On May 20, 2026, Becton Dickinson Euro Finance S.à r.l., a private limited liability company (société à responsabilité limitée) incorporated under the laws of the Grand Duchy of Luxembourg (“Becton Finance”) and an indirect, wholly-owned subsidiary of Becton, Dickinson and Company (“BD”) …Material agreement entered · Form 8-K
- May 12, 2026On May 11, 2026, Becton, Dickinson and Company (“BD”), together with its indirect, wholly-owned subsidiary, Becton Dickinson Euro Finance S.à r.l., a private limited liability company (société à responsabilité limitée) incorporated under the laws of the Grand Duchy of Luxembourg (“Becton Finance”), entered into an …Other event · Form 8-K
- May 7, 2026BD Appoints Vitor Roque Chief Financial Officer.Director or officer change · press release
- May 7, 2026BD Reports Second Quarter Fiscal 2026 Financial Results.Earnings release · press release
- Apr 29, 2026On April 28, 2026, the Board of Directors of Becton, Dickinson and Company (the “Company”) approved the amendment and restatement of the Company’s By-laws (the “By-laws”)Charter/bylaw amendment or fiscal-year change · Form 8-K
- Apr 9, 2026On April 6, 2026, Richard E. Byrd, Executive Vice President and President of the Interventional segment of Becton, Dickinson and Company (“BD”), informed BD of his intention to retire.Director or officer change · Form 8-K
- Apr 2, 2026Non-GAAP Financial Measures Included in the Financial Tables.Earnings release · press release
- Feb 25, 2026On February 25, 2026, Becton, Dickinson and Company (the “Company”) announced the early tender results for its previously announced tender offers (collectively, the “Tender Offers”) to purchase for cash, subject to prioritized acceptance levels, series-specific aggregate principal amount caps, if any (each, an “Offer …Other event · Form 8-K
- Feb 10, 2026On February 10, 2026, Becton, Dickinson and Company (the “Company”) announced that it commenced a series of tender offers to purchase for cash, subject to prioritized acceptance levels, series-specific aggregate principal amount caps, if any, and proration if applicable, up to $1,600,000,000 aggregate purchase price …Other event · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
On our screens:Stocks that buy back more than they dilute
Medical Instruments & Supplies
The closest names by size in the same industry